These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 1983864)

  • 1. Late effects of allogeneic bone marrow transplantation in children.
    Bender-Götze C
    Pediatrician; 1991; 18(1):71-5. PubMed ID: 1983864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cataract in children after autologous bone marrow transplantation. A common, but curable complication].
    Frisk P; Hagberg H; Mandahl A; Söderberg P; Lönnerholm G
    Lakartidningen; 2002 Mar; 99(13):1444-7. PubMed ID: 11989353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Late effects in children after bone marrow transplantation: a review.
    Locatelli F; Giorgiani G; Pession A; Bozzola M
    Haematologica; 1993; 78(5):319-28. PubMed ID: 8314162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term renal function following bone marrow transplantation.
    Grönroos MH; Bolme P; Winiarski J; Berg UB
    Bone Marrow Transplant; 2007 Jun; 39(11):717-23. PubMed ID: 17401393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allogeneic bone marrow transplantation for childhood acute lymphoblastic leukemia in second remission: factors predictive of survival, relapse and graft-versus-host disease.
    Moussalem M; Esperou Bourdeau H; Devergie A; Baruchel A; Ribaud P; Socie G; Parquet N; Traineau R; Hirsch I; Schaison G
    Bone Marrow Transplant; 1995 Jun; 15(6):943-7. PubMed ID: 7581095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of allogeneic bone marrow transplantation on pulmonary function in 80 children in a single paediatric centre.
    Bruno B; Souillet G; Bertrand Y; Werck-Gallois MC; So Satta A; Bellon G
    Bone Marrow Transplant; 2004 Jul; 34(2):143-7. PubMed ID: 15170172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fractionated total-body irradiation, etoposide, and cyclophosphamide followed by allogeneic bone marrow transplantation for patients with high-risk or advanced-stage hematological malignancies.
    Long GD; Amylon MD; Stockerl-Goldstein KE; Negrin RS; Chao NJ; Hu WW; Nademanee AP; Snyder DS; Hoppe RT; Vora N; Wong R; Niland J; Reichardt VL; Forman SJ; Blume KG
    Biol Blood Marrow Transplant; 1997 Dec; 3(6):324-30. PubMed ID: 9502300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allogeneic bone marrow transplantation in the treatment of hematologic diseases.
    Yee GC; McGuire TR
    Clin Pharm; 1985; 4(2):149-60. PubMed ID: 3886273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High prevalence of endocrine dysfunction in long-term survivors after allogeneic bone marrow transplantation for hematologic diseases.
    Tauchmanovà L; Selleri C; Rosa GD; Pagano L; Orio F; Lombardi G; Rotoli B; Colao A
    Cancer; 2002 Sep; 95(5):1076-84. PubMed ID: 12209694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term follow-up of patients undergoing allogeneic bone marrow transplantation for acute myeloid leukemia in first complete remission after cyclophosphamide-total body irradiation and cyclosporine.
    Mehta J; Powles R; Treleaven J; Horton C; Tait D; Meller S; Pinkerton CR; Middleton G; Eisen T; Singhal S
    Bone Marrow Transplant; 1996 Oct; 18(4):741-6. PubMed ID: 8899189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allogeneic bone marrow transplantation: acute and late complications.
    Tabbara IA
    Anticancer Res; 1996; 16(2):1019-26. PubMed ID: 8687093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of splenic irradiation in patients with chronic myeloid leukemia undergoing allogeneic bone marrow transplantation.
    Jabro G; Koc Y; Boyle T; Schenkein DP; Ravalese J; Wazer D; Miller KB
    Biol Blood Marrow Transplant; 1999; 5(3):173-9. PubMed ID: 10392963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful renal transplantation following prior bone marrow transplantation in pediatric patients.
    Thomas SE; Hutchinson RJ; DebRoy M; Magee JC
    Pediatr Transplant; 2004 Oct; 8(5):507-12. PubMed ID: 15367289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Late effects after allogeneic bone marrow transplantation.
    Dicke KA
    Bone Marrow Transplant; 1994; 14 Suppl 4():S11-3. PubMed ID: 7728118
    [No Abstract]   [Full Text] [Related]  

  • 15. Renal involvement in bone marrow transplantation.
    Otani M; Shimojo H; Shiozawa S; Shigematsu H
    Nephrology (Carlton); 2005 Oct; 10(5):530-6. PubMed ID: 16221108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bloodstream infections can develop late (after day 100) and/or in the absence of neutropenia in children receiving allogeneic bone marrow transplantation.
    Romano V; Castagnola E; Dallorso S; Lanino E; Calvi A; Silvestro S; Morreale G; Giacchino R; Dini G
    Bone Marrow Transplant; 1999 Feb; 23(3):271-5. PubMed ID: 10084259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allogeneic bone marrow transplantation for hepatocellular carcinoma: hepatocyte growth factor suppresses graft-vs.-host disease.
    Yoshida Y; Hirano T; Son G; Iimuro Y; Imado T; Iwasaki T; Fujimoto J
    Am J Physiol Gastrointest Liver Physiol; 2007 Dec; 293(6):G1114-23. PubMed ID: 17761834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of related donor peripheral blood and bone marrow transplants: importance of late-onset chronic graft-versus-host disease and infections.
    Anderson D; DeFor T; Burns L; McGlave P; Miller J; Wagner J; Weisdorf D
    Biol Blood Marrow Transplant; 2003 Jan; 9(1):52-9. PubMed ID: 12533742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth in children following irradiation for bone marrow transplantation.
    Bushhouse S; Ramsay NK; Pescovitz OH; Kim T; Robison LL
    Am J Pediatr Hematol Oncol; 1989; 11(2):134-40. PubMed ID: 2665547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allogeneic bone marrow transplantation for children with histiocytic disorders: use of TBI and omission of etoposide in the conditioning regimen.
    Hale GA; Bowman LC; Woodard JP; Cunningham JM; Benaim E; Horwitz EM; Heslop HE; Krance RA; Leung W; Shearer PD; Handgretinger R
    Bone Marrow Transplant; 2003 Jun; 31(11):981-6. PubMed ID: 12774048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.